Alexandre Di Paolo
Company: TriLink BioTechnologies
Job title: Senior Business Development Manager
Seminars:
mRNA Modifications that Matter: Modified Uridine as a Therapeutic Tool 10:45 am
day: Day Two
mRNA Modifications that Matter: Modified Uridine as a Therapeutic Tool 10:45 am
In vitro transcribed (IVT) mRNA has become an effective and scalable therapeutic modality for a wide range of disease indications It has been shown that modifications to wild-type uridine may improve the efficacy of these therapeutics To aid in the synthesis of these compounds, TriLink is developing an extensive platform to manufacture modified uridine and…Read more
day: Day Two